glp-1 and kidneys Understanding receptor agonists their impact on drug discovery GLP-1 receptor agonists in patients

A consultation with a physician helps determine the safest path

Ongoing monitoring includes TSH assessment 68 weeks after starting weight loss injections or dose changes, then every 612 months if stable, with levothyroxine adjustment as needed

Contact: Emily Passer [email protected] Data & methodology Weight loss and engagement: January 2026 analysis of 14,203 Noom GLP-1 Rx Program members who started a GLP-1 Rx plan between December 2024 and February 2025 and logged weight during a measurement week (4, 8, 16, 40 weeks)

A meta-analysis in 2023 examined 93 clinical trials from ClinicalTrials.gov that compared GLP-1RAs direct or indirect impact on DR with placebo, insulin, or oral antidiabetic medications ( A Swedish cohort study examined the impact of multiple GLP-1RAs on the incidence of DR in 2,390 diabetic patients

Also report clay colored stools, which can signal biliary concerns